Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
- 15 July 2009
- journal article
- case report
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 302 (3), 306-314
- https://doi.org/10.1001/jama.2009.1018
Abstract
With improvements in supportive care, both long-term survival following allogeneic hematopoietic stem cell transplantations (HSCTs) and the indications for this procedure have increased. As a result, the number of patients living with long-term toxic effects due to HSCT has increased. A once rare condition of the donor immune cells attacking healthy host tissues, termed chronic graftvs-host disease, has become a more common phenomenon. When chronic graftvs-host disease affects the lung tissue, bronchiolitis obliterans syndrome ensues. Recent data suggest that bronchiolitis obliterans syndrome may affect up to 6% of HSCT recipients and dramatically alters survival, with overall survival of only 13% at 5 years. These statistics have not improved since the first presentation of this disease over 20 years ago. Challenges to the progress of medical management of bronchiolitis obliterans syndrome include difficulties and delays in diagnosis and a paucity of data on pathogenesis to direct new therapies. This article critically evaluates the current diagnostic criteria for bronchiolitis obliterans syndrome and reviews the epidemiology, pathogenesis, and available treatments. Improvements in survival will likely require early disease recognition, allowing for therapeutic modulation of disease prior to the development of irreversible airway obliteration.This publication has 63 references indexed in Scilit:
- Recognizing and Managing Chronic Graft-Versus-Host DiseaseHematology, 2008
- Mechanisms of Airway Obliteration after Lung TransplantationProceedings of the American Thoracic Society, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group ReportTransplantation and Cellular Therapy, 2006
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Risk Factors for Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem-Cell Transplantation for LeukemiaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBlood, 2004
- Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantationBone Marrow Transplantation, 2004
- Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomesTransplantation and Cellular Therapy, 2003
- Bronchiolitis Obliterans Syndrome Complicating Lung or Heart-Lung TransplantationSeminars in Respiratory and Critical Care Medicine, 2003